151 related articles for article (PubMed ID: 20939501)
1. New fluoro derivatives of the pyrazolo[5,1-c][1,2,4]benzotriazine 5-oxide system: evaluation of fluorine binding properties in the benzodiazepine site on γ-aminobutyrric acid type A (GABA(A)) receptor. Design, synthesis, biological, and molecular modeling investigation.
Guerrini G; Ciciani G; Bruni F; Selleri S; Guarino C; Melani F; Montali M; Daniele S; Martini C; Ghelardini C; Norcini M; Ciattini S; Costanzo A
J Med Chem; 2010 Nov; 53(21):7532-48. PubMed ID: 20939501
[TBL] [Abstract][Full Text] [Related]
2. Synthesis, in vivo evaluation, and molecular modeling studies of new pyrazolo[5,1-c][1,2,4]benzotriazine 5-oxide derivatives. Identification of a bifunctional hydrogen bond area related to the inverse agonism.
Guerrini G; Ciciani G; Cambi G; Bruni F; Selleri S; Guarino C; Melani F; Montali M; Martini C; Ghelardini C; Norcini M; Costanzo A
J Med Chem; 2009 Aug; 52(15):4668-82. PubMed ID: 19591485
[TBL] [Abstract][Full Text] [Related]
3. Benzodiazepine receptor ligands. 8: synthesis and pharmacological evaluation of new pyrazolo[5,1-c] [1,2,4]benzotriazine 5-oxide 3- and 8-disubstituted: high affinity ligands endowed with inverse-agonist pharmacological efficacy.
Guerrini G; Costanzo A; Ciciani G; Bruni F; Selleri S; Costagli C; Besnard F; Costa B; Martini C; De Siena G; Malmberg-Aiello P
Bioorg Med Chem; 2006 Feb; 14(3):758-75. PubMed ID: 16214350
[TBL] [Abstract][Full Text] [Related]
4. Benzodiazepine receptor ligands. 4. Synthesis and pharmacological evaluation of 3-heteroaryl-8-chloropyrazolo[5,1-c][1,2,4] benzotriazine 5-oxides.
Costanzo A; Guerrini G; Ciciani G; Bruni F; Selleri S; Costa B; Martini C; Lucacchini A; Aiello PM; Ipponi A
J Med Chem; 1999 Jun; 42(12):2218-26. PubMed ID: 10377227
[TBL] [Abstract][Full Text] [Related]
5. New 3-, 8-disubstituted pyrazolo[5,1-c][1,2,4]benzotriazines useful for studying the interaction with the HBp-3 area (hydrogen bond point area) in the benzodiazepine site on the γ-aminobutyric acid type A (GABAA) receptor.
Guerrini G; Ciciani G; Bruni F; Selleri S; Melani F; Daniele S; Martini C; Costanzo A
Bioorg Med Chem; 2011 May; 19(10):3074-85. PubMed ID: 21530274
[TBL] [Abstract][Full Text] [Related]
6. Novel 3-iodo-8-ethoxypyrazolo[5,1-c][1,2,4]benzotriazine 5-oxide as promising lead for design of alpha5-inverse agonist useful tools for therapy of mnemonic damage.
Guerrini G; Ciciani G; Cambi G; Bruni F; Selleri S; Besnard F; Montali M; Martini C; Ghelardini C; Galeotti N; Costanzo A
Bioorg Med Chem; 2007 Apr; 15(7):2573-86. PubMed ID: 17306981
[TBL] [Abstract][Full Text] [Related]
7. Novel 3-aroylpyrazolo[5,1-c][1,2,4]benzotriazine 5-oxides 8-substituted, ligands at GABAA/benzodiazepine receptor complex: synthesis, pharmacological and molecular modeling studies.
Guerrini G; Ciciani G; Cambi G; Bruni F; Selleri S; Melani F; Montali M; Martini C; Ghelardini C; Norcini M; Costanzo A
Bioorg Med Chem; 2008 Apr; 16(8):4471-89. PubMed ID: 18325771
[TBL] [Abstract][Full Text] [Related]
8. Synthesis and structure-activity relationship studies in translocator protein ligands based on a pyrazolo[3,4-b]quinoline scaffold.
Cappelli A; Bini G; Valenti S; Giuliani G; Paolino M; Anzini M; Vomero S; Giorgi G; Giordani A; Stasi LP; Makovec F; Ghelardini C; Di Cesare Mannelli L; Concas A; Porcu P; Biggio G
J Med Chem; 2011 Oct; 54(20):7165-75. PubMed ID: 21916402
[TBL] [Abstract][Full Text] [Related]
9. 2,3,7-Trisubstituted pyrazolo[1,5-d][1,2,4]triazines: functionally selective GABAA alpha3-subtype agonists.
Carling RW; Russell MG; Moore KW; Mitchinson A; Guiblin A; Smith A; Wafford KA; Marshall G; Atack JR; Street LJ
Bioorg Med Chem Lett; 2006 Jul; 16(13):3550-4. PubMed ID: 16621541
[TBL] [Abstract][Full Text] [Related]
10. Development of ligands at γ-aminobutyrric acid type A (GABAA) receptor subtype as new agents for pain relief.
Guerrini G; Ciciani G; Bruni F; Selleri S; Martini C; Daniele S; Ghelardini C; Di Cesare Mannelli L; Costanzo A
Bioorg Med Chem; 2011 Dec; 19(24):7441-52. PubMed ID: 22094278
[TBL] [Abstract][Full Text] [Related]
11. A novel selective GABA(A) alpha1 receptor agonist displaying sedative and anxiolytic-like properties in rodents.
Selleri S; Bruni F; Costagli C; Costanzo A; Guerrini G; Ciciani G; Gratteri P; Besnard F; Costa B; Montali M; Martini C; Fohlin J; De Siena G; Aiello PM
J Med Chem; 2005 Oct; 48(21):6756-60. PubMed ID: 16220991
[TBL] [Abstract][Full Text] [Related]
12. A new class of pyrazolo[5,1-c][1,2,4]triazines as γ-aminobutyric type A (GABA
Guerrini G; Ciciani G; Daniele S; Martini C; Costagli C; Guarino C; Selleri S
Bioorg Med Chem; 2018 May; 26(9):2475-2487. PubMed ID: 29650463
[TBL] [Abstract][Full Text] [Related]
13. Synthesis and benzodiazepine receptor affinity of pyrazolo[1,5-a]pyrimidine derivatives. 3. New 6-(3-thienyl) series as alpha 1 selective ligands.
Selleri S; Bruni F; Costagli C; Costanzo A; Guerrini G; Ciciani G; Gratteri P; Bonaccini C; Malmberg Aiello P; Besnard F; Renard S; Costa B; Martini C
J Med Chem; 2003 Jan; 46(2):310-3. PubMed ID: 12519068
[TBL] [Abstract][Full Text] [Related]
14. The anxioselective agent 7-(2-chloropyridin-4-yl)pyrazolo-[1,5-a]-pyrimidin-3-yl](pyridin-2-yl)methanone (DOV 51892) is more efficacious than diazepam at enhancing GABA-gated currents at alpha1 subunit-containing GABAA receptors.
Popik P; Kostakis E; Krawczyk M; Nowak G; Szewczyk B; Krieter P; Chen Z; Russek SJ; Gibbs TT; Farb DH; Skolnick P; Lippa AS; Basile AS
J Pharmacol Exp Ther; 2006 Dec; 319(3):1244-52. PubMed ID: 16971504
[TBL] [Abstract][Full Text] [Related]
15. Design, synthesis, and biological evaluation of C9- and C2-substituted pyrazolo[4,3-e]-1,2,4-triazolo[1,5-c]pyrimidines as new A2A and A3 adenosine receptors antagonists.
Baraldi PG; Fruttarolo F; Tabrizi MA; Preti D; Romagnoli R; El-Kashef H; Moorman A; Varani K; Gessi S; Merighi S; Borea PA
J Med Chem; 2003 Mar; 46(7):1229-41. PubMed ID: 12646033
[TBL] [Abstract][Full Text] [Related]
16. Ethyl 8-fluoro-6-(3-nitrophenyl)-4H-imidazo[1,5-a][1,4]benzodiazepine-3-carboxylate as novel, highly potent, and safe antianxiety agent.
Anzini M; Braile C; Valenti S; Cappelli A; Vomero S; Marinelli L; Limongelli V; Novellino E; Betti L; Giannaccini G; Lucacchini A; Ghelardini C; Norcini M; Makovec F; Giorgi G; Ian Fryer R
J Med Chem; 2008 Aug; 51(15):4730-43. PubMed ID: 18637672
[TBL] [Abstract][Full Text] [Related]
17. Discovery of imidazo[1,2-b][1,2,4]triazines as GABA(A) alpha2/3 subtype selective agonists for the treatment of anxiety.
Russell MG; Carling RW; Street LJ; Hallett DJ; Goodacre S; Mezzogori E; Reader M; Cook SM; Bromidge FA; Newman R; Smith AJ; Wafford KA; Marshall GR; Reynolds DS; Dias R; Ferris P; Stanley J; Lincoln R; Tye SJ; Sheppard WF; Sohal B; Pike A; Dominguez M; Atack JR; Castro JL
J Med Chem; 2006 Feb; 49(4):1235-8. PubMed ID: 16480260
[TBL] [Abstract][Full Text] [Related]
18. Cardiovascular characterization of pyrrolo[2,1-d][1,5]benzothiazepine derivatives binding selectively to the peripheral-type benzodiazepine receptor (PBR): from dual PBR affinity and calcium antagonist activity to novel and selective calcium entry blockers.
Campiani G; Fiorini I; De Filippis MP; Ciani SM; Garofalo A; Nacci V; Giorgi G; Sega A; Botta M; Chiarini A; Budriesi R; Bruni G; Romeo MR; Manzoni C; Mennini T
J Med Chem; 1996 Jul; 39(15):2922-38. PubMed ID: 8709127
[TBL] [Abstract][Full Text] [Related]
19. Benzodiazepine receptor ligands. III. Synthesis and biological evaluation of 2- and/or 3-substituted pyrazolo[5,1-c][1,2,4]benzotriazine 5-oxides.
Guerrini G; Costanzo A; Bruni F; Ciciani G; Selleri S; Gratteri P; Costa B; Martini C; Lucacchini A
Farmaco; 1999 Jun; 54(6):375-89. PubMed ID: 10576777
[TBL] [Abstract][Full Text] [Related]
20. Synthesis of novel cognition enhancers with pyrazolo[5,1-c][1,2,4]benzotriazine core acting at γ-aminobutyric acid type A (GABA(A)) receptor.
Guerrini G; Ciciani G; Costanzo A; Daniele S; Martini C; Ghelardini C; Di Cesare Mannelli L; Ciattini S
Bioorg Med Chem; 2013 Apr; 21(8):2186-2198. PubMed ID: 23490154
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
